MEI Pharma Q1 EPS $8.46 Beats $(2.12) Estimate, Sales $65.30M Up From $8.73M YoY
Author: Benzinga Newsdesk | November 09, 2023 06:08pm
MEI Pharma (NASDAQ:
MEIP) reported quarterly earnings of $8.46 per share which beat the analyst consensus estimate of $(2.12) by 499.06 percent. This is a 425.38 percent increase over losses of $(2.60) per share from the same period last year. The company reported $65.30 million in sales this quarter. This is a 647.96 percent increase over sales of $8.73 million the same period last year.
Posted In: MEIP